| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 6.78e-05 | 9 | 28 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 7.51e-04 | 807 | 28 | 6 | GO:0016788 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 1.35e-03 | 157 | 28 | 3 | GO:0052689 | |
| GeneOntologyMolecularFunction | miRNA binding | 2.06e-03 | 48 | 28 | 2 | GO:0035198 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 3.40e-03 | 62 | 28 | 2 | GO:0061980 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 5.07e-03 | 76 | 28 | 2 | GO:0098631 | |
| GeneOntologyMolecularFunction | collagen binding | 5.74e-03 | 81 | 28 | 2 | GO:0005518 | |
| Domain | VWA | 3.17e-03 | 56 | 28 | 2 | PF00092 | |
| Domain | VWFA | 6.68e-03 | 82 | 28 | 2 | PS50234 | |
| Domain | VWA | 7.00e-03 | 84 | 28 | 2 | SM00327 | |
| Domain | VWF_A | 9.61e-03 | 99 | 28 | 2 | IPR002035 | |
| Domain | - | 1.37e-02 | 119 | 28 | 2 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 1.37e-02 | 119 | 28 | 2 | IPR029058 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 19343734 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.18e-06 | 861 | 28 | 7 | 36931259 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.19e-05 | 430 | 28 | 5 | 35044719 | |
| Pubmed | 2.32e-05 | 209 | 28 | 4 | 36779422 | ||
| Pubmed | 7.00e-05 | 549 | 28 | 5 | 38280479 | ||
| Pubmed | 1.43e-04 | 22 | 28 | 2 | 38736483 | ||
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 2.17e-04 | 27 | 28 | 2 | 25269881 | |
| Pubmed | RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway. | 2.67e-04 | 156 | 28 | 3 | 26170170 | |
| Pubmed | 2.98e-04 | 162 | 28 | 3 | 25796446 | ||
| Pubmed | Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. | 3.05e-04 | 32 | 28 | 2 | 17883393 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 4.06e-04 | 180 | 28 | 3 | 35198878 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 4.19e-04 | 182 | 28 | 3 | 32239614 | |
| Pubmed | 7.28e-04 | 220 | 28 | 3 | 24550385 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 7.67e-04 | 922 | 28 | 5 | 27609421 | |
| Interaction | SAMD4B interactions | 2.01e-05 | 122 | 27 | 4 | int:SAMD4B | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.71e-06 | 189 | 28 | 4 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 5.71e-06 | 189 | 28 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 6.20e-06 | 193 | 28 | 4 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.20e-06 | 193 | 28 | 4 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.33e-06 | 194 | 28 | 4 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.46e-06 | 195 | 28 | 4 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.46e-06 | 195 | 28 | 4 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.72e-06 | 197 | 28 | 4 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.72e-06 | 197 | 28 | 4 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.14e-06 | 200 | 28 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.14e-06 | 200 | 28 | 4 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-04 | 148 | 28 | 3 | d60f93311cfa718d026a0dbf61771bbbcbb79146 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-04 | 148 | 28 | 3 | 44128692824ca419fface0af41099c17135933ce | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 150 | 28 | 3 | b30f52b94ce772632a1f2f5e0837db876cf92651 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 150 | 28 | 3 | 05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 153 | 28 | 3 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 157 | 28 | 3 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 158 | 28 | 3 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 164 | 28 | 3 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 166 | 28 | 3 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 167 | 28 | 3 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 167 | 28 | 3 | 1e144c03409df94ccd39760842590e8ea7487e29 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 167 | 28 | 3 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.54e-04 | 167 | 28 | 3 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.59e-04 | 169 | 28 | 3 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.59e-04 | 169 | 28 | 3 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-04 | 170 | 28 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 170 | 28 | 3 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-04 | 171 | 28 | 3 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-04 | 172 | 28 | 3 | 8b396d1e9173da104d467e42286379fe07cee257 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-04 | 177 | 28 | 3 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | Control-Lymphocyte-T_NK-CD4_CTL|Control / Disease, Lineage and Cell Type | 1.85e-04 | 178 | 28 | 3 | 32fbb7a8d7daa7cb37f42923514acbb9090e6811 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-04 | 178 | 28 | 3 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-04 | 178 | 28 | 3 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-04 | 179 | 28 | 3 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-04 | 179 | 28 | 3 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-04 | 180 | 28 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-04 | 180 | 28 | 3 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 181 | 28 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 181 | 28 | 3 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 181 | 28 | 3 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 181 | 28 | 3 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-04 | 181 | 28 | 3 | 6c55985e464cb0f5fb3362e9fd90351b671950f7 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.98e-04 | 182 | 28 | 3 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-04 | 182 | 28 | 3 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-04 | 182 | 28 | 3 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-04 | 184 | 28 | 3 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-04 | 185 | 28 | 3 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 11c147f3f5570c4761d2bcff3bad28146b4a5861 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.14e-04 | 187 | 28 | 3 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 187 | 28 | 3 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 187 | 28 | 3 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.18e-04 | 188 | 28 | 3 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.18e-04 | 188 | 28 | 3 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.21e-04 | 189 | 28 | 3 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 189 | 28 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 189 | 28 | 3 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 189 | 28 | 3 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-04 | 190 | 28 | 3 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-04 | 190 | 28 | 3 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 191 | 28 | 3 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.28e-04 | 191 | 28 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 191 | 28 | 3 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 191 | 28 | 3 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-04 | 191 | 28 | 3 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.32e-04 | 192 | 28 | 3 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 192 | 28 | 3 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.32e-04 | 192 | 28 | 3 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-04 | 194 | 28 | 3 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.39e-04 | 194 | 28 | 3 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 195 | 28 | 3 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-04 | 196 | 28 | 3 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-04 | 196 | 28 | 3 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 2.46e-04 | 196 | 28 | 3 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-04 | 196 | 28 | 3 | 37a5f9f3988778655580bd0383811bb4930c1551 | |
| ToppCell | C_05|World / shred on cell type and cluster | 2.46e-04 | 196 | 28 | 3 | bf4dfb460a153dbafb2b9b12b360c8757cec22cd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-04 | 196 | 28 | 3 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.50e-04 | 197 | 28 | 3 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.54e-04 | 198 | 28 | 3 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.57e-04 | 199 | 28 | 3 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | eb2d1b7e875c5bf833e7a80b43282e12893c34e9 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.57e-04 | 199 | 28 | 3 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.57e-04 | 199 | 28 | 3 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.57e-04 | 199 | 28 | 3 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-04 | 200 | 28 | 3 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-04 | 200 | 28 | 3 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-04 | 200 | 28 | 3 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.61e-04 | 200 | 28 | 3 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-04 | 200 | 28 | 3 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 28 | 3 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 28 | 3 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| Drug | 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane | 1.46e-06 | 2 | 28 | 2 | ctd:C572723 | |
| Drug | bombesin (7-14) | 1.46e-06 | 2 | 28 | 2 | ctd:C118536 | |
| Drug | 2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid | 1.46e-06 | 2 | 28 | 2 | ctd:C544380 | |
| Drug | Valerates | 4.37e-06 | 3 | 28 | 2 | ctd:D014631 | |
| Drug | Aminocaproic Acid | 3.05e-05 | 7 | 28 | 2 | ctd:D015119 | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 2800_UP | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 5118_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 4546_DN | |
| Drug | acryloyl chloride | 1.52e-04 | 15 | 28 | 2 | CID000013140 | |
| Drug | Vydate | 1.52e-04 | 15 | 28 | 2 | CID000031657 | |
| Drug | PTMG | 1.73e-04 | 16 | 28 | 2 | CID003084433 | |
| Drug | parazoanthoxanthin A | 3.02e-04 | 21 | 28 | 2 | CID000323259 | |
| Drug | tetraethylarsonium | 3.63e-04 | 23 | 28 | 2 | CID005289426 | |
| Drug | AC1L1UD1 | 4.30e-04 | 25 | 28 | 2 | CID000035754 | |
| Drug | difenoconazole | 4.30e-04 | 25 | 28 | 2 | ctd:C115058 | |
| Drug | propoxur | 5.40e-04 | 28 | 28 | 2 | CID000004944 | |
| Drug | C16-ceramide | 1.05e-03 | 39 | 28 | 2 | CID000002498 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 6.30e-04 | 39 | 28 | 2 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | Memory Disorders | 7.65e-04 | 43 | 28 | 2 | C0025261 | |
| Disease | Memory Loss | 7.65e-04 | 43 | 28 | 2 | C0751295 | |
| Disease | Age-Related Memory Disorders | 7.65e-04 | 43 | 28 | 2 | C0751292 | |
| Disease | Memory Disorder, Spatial | 7.65e-04 | 43 | 28 | 2 | C0751294 | |
| Disease | Memory Disorder, Semantic | 7.65e-04 | 43 | 28 | 2 | C0751293 | |
| Disease | Memory impairment | 8.01e-04 | 44 | 28 | 2 | C0233794 | |
| Disease | urinary metabolite measurement | 1.59e-03 | 245 | 28 | 3 | EFO_0005116 | |
| Disease | S-7-hydroxywarfarin to S-warfarin ratio measurement | 2.69e-03 | 81 | 28 | 2 | EFO_0803334 | |
| Disease | sugar consumption measurement | 5.79e-03 | 120 | 28 | 2 | EFO_0010158 | |
| Disease | Papillary Renal Cell Carcinoma | 6.56e-03 | 128 | 28 | 2 | C1306837 | |
| Disease | Renal Cell Carcinoma | 6.56e-03 | 128 | 28 | 2 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 6.56e-03 | 128 | 28 | 2 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 6.56e-03 | 128 | 28 | 2 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 6.56e-03 | 128 | 28 | 2 | C1266044 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPHGYEIEFIFGIPL | 476 | P22303 | |
| YGGVRIVPVEHLTPF | 1126 | P53355 | |
| YVVVPPALNPVIYGV | 281 | Q8NGH9 | |
| IGPYQPNVPVGIDYV | 781 | P43243 | |
| LEGYEIYVTPGVQPP | 1996 | Q14676 | |
| KVYIIAHVPVGYLPS | 246 | Q92484 | |
| AVGLPSIPVHPIGYY | 286 | Q04609 | |
| PYNIYPHGITDVRPL | 491 | P00451 | |
| LGPAVVPHQYYGVTP | 451 | Q14671 | |
| PGPGFGIYAVVHLLL | 1491 | Q5TH69 | |
| HPGILYVIPAVYGVI | 36 | P30550 | |
| ETIYHGVPVVGIPLF | 366 | Q16880 | |
| RYEVHPYGTLPVGPG | 951 | O75578 | |
| LLPPGYFPAGRYVVV | 511 | Q3KP66 | |
| SKYLHVGYIVPPAPE | 196 | O60749 | |
| PEGTPVELYYTVHPG | 221 | Q8N3T6 | |
| GYVIHLAPPSEYPGA | 31 | Q9UL19 | |
| RERHPYTVPYGPQGV | 491 | Q15678 | |
| YYVLEGVPHQLLPPE | 986 | O15357 | |
| PPYLFPIGDVAIVYT | 611 | Q4LDE5 | |
| VVPIYEGYPLPSITG | 226 | Q9Y615 | |
| QIICYPGTGHYIEPP | 351 | Q8N9L9 | |
| HLVSYPTIPPGITVY | 301 | O43529 | |
| YVIIYGTPGVPLIQL | 2951 | O60673 | |
| EVQTLPYLPHYIPGV | 151 | O15027 | |
| VKTPAGHVYEYIPHP | 741 | O94991 | |
| PPVIYVPVGIHGYIR | 331 | Q9UPX0 | |
| VGLPSIPVHPIGYYD | 481 | Q3C1V9 | |
| GYVPNLLGIIPYAGI | 346 | Q6NUK1 |